Panblok H7 Vaccine Adjuvanted With AS03 or MF59

NCT03283319 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

366

Enrollment

FED

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: 3.75 ug Panblok H7
BIOLOGICAL: 7.5 ug Panblok H7
BIOLOGICAL: 15 ug Panblok H7
BIOLOGICAL: MF59
BIOLOGICAL: AS03

Sponsor

Biomedical Advanced Research and Development Authority

Collaborators

[object Object]